RDY (RDY) Earnings Call Analysis

14/25

Growth 3 Margin 1 Expansion 5 Platform 1 Financial 4

latest quarter score

Earnings Reports

14
Dr. Reddy’s (RDY) Q4 2026: Semaglutide Launches Target 12M Units, Offsetting North America Generic Drag
June 17, 2026
16
Dr. Reddy’s (RDY) Q3 2026: India Franchise Surges 19% as U.S. Generics Faces 16% Decline
June 15, 2026
17
Dr. Reddy's Laboratories (RDY) Q2 2026: 10% Revenue Growth Driven by Consumer Healthcare and Emerging Markets Expansion
October 24, 2025
19
Dr. Reddy's Laboratories (RDY) Q1 FY26: 11% Revenue Growth Amid U.S. Pricing Pressure and Pipeline Advancements
July 23, 2025
19
Dr. Reddy’s Laboratories (RDY) Q4 2025: 20% Revenue Growth Accelerates Global Generics Expansion Amid Margin Pressure
May 09, 2025

Browse all companies